Actively Recruiting
Study on Clinical Features, Treatment Mode and Survival of Bone and Soft Tissue Tumors
Led by Henan Cancer Hospital · Updated on 2023-09-01
6000
Participants Needed
1
Research Sites
521 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
It is planned to prospectively collect, collate and report real-world clinical data of BSTS patients treated in our hospital in the next ten years to evaluate the changes in clinical characteristics, treatment patterns and survival information of these patients, in order to provide reference for clinical treatment and research of this type of tumor.
CONDITIONS
Official Title
Study on Clinical Features, Treatment Mode and Survival of Bone and Soft Tissue Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- All ages, male and female
- Pathological diagnosis of bone and soft tissue tumors (BSTS) at this hospital
- At least one hospitalization at this hospital
- Target lesions can be evaluated using RECIST Version 1.1 criteria to measure diameter changes
You will not qualify if you...
- No definite pathological diagnosis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Bone and Soft Tissue ,Henan Cancer Hospital
Zhengzhou, Henan, China, 450008
Actively Recruiting
Research Team
W
Wang Jiaqiang, Dr.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here